Recent Finacing
Recent Raise
InflaRx is a Jena-based biopharma developing anti-C5a monoclonal antibodies (lead IFX-1) that selectively block C5a while preserving MAC, advancing Phase II clinical programs for inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
